Implantable Bioartificial Kidney MarketSize and Trends

Implantable Bioartificial Kidney Market: Drivers

Increasing number of chronic kidney disease patients, rising number of kidney failure incidences, and long waiting list for kidney transplants is expected to boost the global implantable bioartificial kidney market growth over the forecast period. For instance, according to Kidney Health Australia, 2010, the cost of treating all current and new cases of End Stage Kidney Disease (ESKD) will reach up to US$ 12 billion by 2020. Moreover, according to the Centers for Disease Control & Prevention (CDC), around 15% of the adults in the U.S. were estimated to have chronic kidney disease in 2017. CDC states that around 96% of the people with kidney damage or hampered kidney function are not aware of having chronic kidney disease. These factors are expected to drive the global implantable bioartificial kidney market growth over the forecast period.

Individual government organizations and manufacturers are working towards increasing the awareness of kidney diseases. For instance, American Kidney Fund (AKF) launched a comprehensive new kidney disease education portal in May 2018. The education portal called as ‘CKD Central’ will provide information and resources on chronic kidney disease (CKD). Moreover, The Kidney Project is a national research project, which aims to create a small, surgically implanted, and free-standing bioartificial kidney to treat end stage renal disease (ESRD). This kidney is expected to provide ESRD patients with a new option beyond the short-term solution of renal dialysis and the costly kidney transplant for which donor organs are limited.

Market Trends